Stem cell therapy for neonatal hypoxic-ischemic brain injury

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Various varieties of stem cells and methods of their administration are proposed as therapeutic modalities for neonatal hypoxic–ischemic (HI) brain injury. The widespread use of stem cells for this purpose and others, despite the lack of strong clinical evidence for their efficacy in most clinical situations, makes it incumbent to review the pathophysiology of the clinical condition of neonatal HI brain injury, the preclinical data dealing with animal HI injury, and the available clinical studies.

Original languageEnglish (US)
Title of host publicationCell Therapy for Brain Injury
PublisherSpringer International Publishing
Pages307-320
Number of pages14
ISBN (Electronic)9783319150635
ISBN (Print)9783319150628
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Brain Injuries
Brain
Stem Cells
Animals
Wounds and Injuries
Therapeutics
Clinical Studies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Neuroscience(all)

Cite this

Carroll, J. E. (2015). Stem cell therapy for neonatal hypoxic-ischemic brain injury. In Cell Therapy for Brain Injury (pp. 307-320). Springer International Publishing. https://doi.org/10.1007/978-3-319-15063-5_16

Stem cell therapy for neonatal hypoxic-ischemic brain injury. / Carroll, James Edwin.

Cell Therapy for Brain Injury. Springer International Publishing, 2015. p. 307-320.

Research output: Chapter in Book/Report/Conference proceedingChapter

Carroll, JE 2015, Stem cell therapy for neonatal hypoxic-ischemic brain injury. in Cell Therapy for Brain Injury. Springer International Publishing, pp. 307-320. https://doi.org/10.1007/978-3-319-15063-5_16
Carroll JE. Stem cell therapy for neonatal hypoxic-ischemic brain injury. In Cell Therapy for Brain Injury. Springer International Publishing. 2015. p. 307-320 https://doi.org/10.1007/978-3-319-15063-5_16
Carroll, James Edwin. / Stem cell therapy for neonatal hypoxic-ischemic brain injury. Cell Therapy for Brain Injury. Springer International Publishing, 2015. pp. 307-320
@inbook{7cce1a8f090d4c8cbf1be333ec462855,
title = "Stem cell therapy for neonatal hypoxic-ischemic brain injury",
abstract = "Various varieties of stem cells and methods of their administration are proposed as therapeutic modalities for neonatal hypoxic–ischemic (HI) brain injury. The widespread use of stem cells for this purpose and others, despite the lack of strong clinical evidence for their efficacy in most clinical situations, makes it incumbent to review the pathophysiology of the clinical condition of neonatal HI brain injury, the preclinical data dealing with animal HI injury, and the available clinical studies.",
author = "Carroll, {James Edwin}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-15063-5_16",
language = "English (US)",
isbn = "9783319150628",
pages = "307--320",
booktitle = "Cell Therapy for Brain Injury",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Stem cell therapy for neonatal hypoxic-ischemic brain injury

AU - Carroll, James Edwin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Various varieties of stem cells and methods of their administration are proposed as therapeutic modalities for neonatal hypoxic–ischemic (HI) brain injury. The widespread use of stem cells for this purpose and others, despite the lack of strong clinical evidence for their efficacy in most clinical situations, makes it incumbent to review the pathophysiology of the clinical condition of neonatal HI brain injury, the preclinical data dealing with animal HI injury, and the available clinical studies.

AB - Various varieties of stem cells and methods of their administration are proposed as therapeutic modalities for neonatal hypoxic–ischemic (HI) brain injury. The widespread use of stem cells for this purpose and others, despite the lack of strong clinical evidence for their efficacy in most clinical situations, makes it incumbent to review the pathophysiology of the clinical condition of neonatal HI brain injury, the preclinical data dealing with animal HI injury, and the available clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=84943412980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943412980&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-15063-5_16

DO - 10.1007/978-3-319-15063-5_16

M3 - Chapter

SN - 9783319150628

SP - 307

EP - 320

BT - Cell Therapy for Brain Injury

PB - Springer International Publishing

ER -